Restylane Refyne, Restylane Defyne Injectable Gels
FDA premarket approval P140029/S024 · decided 2020-03-19
Approval details
- PMA number
- P140029
- Supplement
- S024
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Restylane Refyne, Restylane Defyne Injectable Gels
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Q-Med AB
- Date received
- 2020-02-18
- Decision date
- 2020-03-19
- Days to decision
- 30 days
- Decision code
- OK30
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Uppsala
- Statement
- Revision of the criteria for the visual inspection of filled and sterilized syringes performed during manufacturing of Restylane Refyne and Restylane Defyne.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.